Therapy News and Research

RSS

New genetic risk score could help guide screening decisions for prostate cancer

One of the biggest challenges in treating prostate cancer is distinguishing men who have aggressive and potentially lethal disease from men whose cancer is slow-growing and unlikely to metastasize.

20 Feb 2018

Therapeutic target for glaucoma could have treatment ramifications for Alzheimer’s and Parkinson’s

A therapeutic target to preserve vision in glaucoma patients could have treatment ramifications for age-related neurodegenerative disorders like Alzheimer's and Parkinson's, according to findings released today in the Proceedings of the National Academy of Sciences.

20 Feb 2018

UH Cleveland Medical Center explores novel treatments for uterine fibroids

Uterine fibroids, or uterine myomas, can cause symptoms that include unusually long and heavy menstrual flow, pain, enlarged uterus, pressure on the bladder and rectum, and uncomfortable intercourse.

19 Feb 2018

New wearable electronics could be game-changer for stroke rehabilitation

A groundbreaking new wearable designed to be worn on the throat could be a game-changer in the field of stroke rehabilitation.

19 Feb 2018

Clinical trial studying type 1 diabetes reaches full enrollment

A clinical trial studying type 1 diabetes has reached full enrollment. The Sanford Project: T-Rex Study, a Phase 2 clinical trial conducted collaboratively by Sanford Health and Caladrius Biosciences, Inc., has completed enrollment of 110 children with type 1 diabetes. The study started with two sites at Sanford Health in Sioux Falls, South Dakota, and Fargo, North Dakota, and expanded to 13 additional sites across the United States.

19 Feb 2018

Scientists develop water-soluble warped nanographene for bioimaging

An international team of scientists has developed a water-soluble "warped nanographene", a flexible molecule that is biocompatible and shows promise for fluorescent cell imaging.

19 Feb 2018

Myriad's EndoPredict offers better prediction of breast cancer recurrence, analysis shows

Myriad Genetics, Inc. today announced that a comparative analysis of commercially available prognostic breast cancer tests in patients with early-stage breast cancer has been published in JAMA Oncology.

19 Feb 2018

FDA approves first treatment to reduce risk of NSCLC progression

The U.S. Food and Drug Administration today approved Imfinzi (durvalumab) for the treatment of patients with stage III non-small cell lung cancer (NSCLC) whose tumors are not able to be surgically removed (unresectable) and whose cancer has not progressed after treatment with chemotherapy and radiation (chemoradiation).

18 Feb 2018

Stem cell vaccine helps protect mice against numerous cancers, finds study

Lab mice injected with inactivated induced pluripotent stem cells (iPSCs) displayed a significant immune response against lung, breast, and skin cancers. The vaccine also prevented relapses in animals with removed tumors.

16 Feb 2018

Study could lead to new therapies to improve movement control in stroke survivors

New research published in The Journal of Physiology could open the door to new therapies to improve the movement of arms and hands of stroke survivors.

16 Feb 2018

Diplomats in Havana and their mysterious concussion-like symptoms

American diplomats who were posted to Havana were reported to have symptoms similar to concussions suffered after a head injury. This was despite the fact that none of them had had any head trauma. Initially it was speculated that they could have been victims to a “sonic attack” to their brains. However the Federal Bureau of Investigation (FBI) ruled out any such involvement last month.

16 Feb 2018

Simulated hippotherapy has potential to improve quality of life for children with cerebral palsy

Robotically assisted hippotherapy, a type of therapy that simulates the repetitive and rhythmic movement of a horse, has the potential to improve trunk control and quality of life for children with cerebral palsy, according to science presented this week at the Association of Academic Physiatrists Annual Meeting in Atlanta.

15 Feb 2018

Genetic risk score could help predict patient's quality of life after traumatic brain injury

A new study presented this week at the Association of Academic Physiatrists Annual Meeting in Atlanta found that a genetic risk score could help predict a patient's quality of life after a traumatic brain injury. One day, physicians could have a simple, early method to forecast a patient's recovery and personalize therapy to maximize their quality of life down the road.

15 Feb 2018

New guidelines offer recommendations for assessment, management of immunotherapy side effects

Immunotherapy with immune checkpoint inhibitors is the first of a new generation of immunotherapy treatments, revolutionizing treatment for many different types of cancer. By unleashing the body's immune system to attack cancer, these treatments can send even the most hard-to-treat cancers into lasting remission.

15 Feb 2018

MRI and machine learning could predict whether OCD patients will benefit from treatment

Washing hands needlessly dozens of times of day. Spending so much time perfecting schoolwork that it never gets turned in.

15 Feb 2018

Learning stress-reducing techniques may benefit people with epilepsy

Learning techniques to help manage stress may help people with epilepsy reduce how often they have seizures, according to a study published in the February 14, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology.

15 Feb 2018

New NK cell-based immunotherapy effective against several types of leukemia

Researchers at Karolinska Institutet in Sweden have explored NK cell-based immunotherapy on patients with treatment-resistant leukemia. The study, which is published in the scientific journal Clinical Cancer Research, shows that the new therapy is effective against several types of leukemia.

15 Feb 2018

Potential new principle for treatment of multiple forms of cancer

A study published in Science Translational Medicine shows that small molecules that specifically inhibit an important selenium-containing enzyme may be useful in combating cancer. When researchers at Karolinska Institutet treated cancer in mice using these molecules, they observed rapid tumoricidal effects.

15 Feb 2018

Cervical tumors may be vulnerable to therapies that attack cancer's fuel supply, study shows

Cancer therapies have improved -- in some cases dramatically -- over the past two decades, but treatment for cervical cancer has remained largely unchanged. All patients receive radiation and chemotherapy, yet despite the aggressive approach, the regimen fails in about one-third of patients with cervical cancer that has spread beyond the cervix but not outside the pelvis.

15 Feb 2018

FDA approves new treatment for non-metastatic, castration-resistant prostate cancer

The U.S. Food and Drug Administration today approved Erleada (apalutamide) for the treatment of patients with prostate cancer that has not spread (non-metastatic), but that continues to grow despite treatment with hormone therapy (castration-resistant). This is the first FDA-approved treatment for non-metastatic, castration-resistant prostate cancer.

15 Feb 2018

Therapy News and Research

New genetic risk score could help guide screening decisions for prostate cancer

Therapeutic target for glaucoma could have treatment ramifications for Alzheimer’s and Parkinson’s

UH Cleveland Medical Center explores novel treatments for uterine fibroids

New wearable electronics could be game-changer for stroke rehabilitation

Clinical trial studying type 1 diabetes reaches full enrollment

Scientists develop water-soluble warped nanographene for bioimaging

Myriad's EndoPredict offers better prediction of breast cancer recurrence, analysis shows

FDA approves first treatment to reduce risk of NSCLC progression

Stem cell vaccine helps protect mice against numerous cancers, finds study

Study could lead to new therapies to improve movement control in stroke survivors

Diplomats in Havana and their mysterious concussion-like symptoms

Simulated hippotherapy has potential to improve quality of life for children with cerebral palsy

Genetic risk score could help predict patient's quality of life after traumatic brain injury

New guidelines offer recommendations for assessment, management of immunotherapy side effects

MRI and machine learning could predict whether OCD patients will benefit from treatment

Learning stress-reducing techniques may benefit people with epilepsy

New NK cell-based immunotherapy effective against several types of leukemia

Potential new principle for treatment of multiple forms of cancer

Cervical tumors may be vulnerable to therapies that attack cancer's fuel supply, study shows

FDA approves new treatment for non-metastatic, castration-resistant prostate cancer

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News